<DOC>
	<DOCNO>NCT01193231</DOCNO>
	<brief_summary>STUDY OBJECTIVE : To evaluate safety efficacy Acuvail 0.45 % administer BID increase corneal re-epithelialization , decrease time zero pain post-photorefractive keratectomy ( PRK ) surgery , PRK enhancement assessment 6 month post op CLINICAL HYPOTHESES : Acuvail 0.45 % administered twice daily superior Systane Ultra lubricant treat post PRK pain OVERAL STUDY DESIGN : Structure : Single-center , randomize , open label , contralateral ( one eye receive Acuvail , one eye Systane Ultra ) Treatment Group : Patients randomize eye receive Acuvail 0.45 % Assignment : Acuvail 0.45 % one eye , Systane Ultra contralateral eye Duration : 6.5 month Controls : Systane Ultra preservative-free lubricant Dosage/Dose Regimen : Study medication administer randomized eye post op day 1-2 BID Visit Schedule : Screening ( baseline ) , Day 2-30 ( Surgery ) , post surgery Day 1 day corneal re-epithelialization , post surgery month 1 , 3 , 6 . Number Patients : 10 ( 20 eye ) Condition/Disease : patient undergo bilateral PRK surgery</brief_summary>
	<brief_title>A 6 Month Study Evaluate Safety , Analgesic Efficacy ACUVAIL™ ( Ketorolac Tromethamine Ophthalmic Solution ) 0.45 % , Post-PRK Corneal Wound Healing</brief_title>
	<detailed_description>1 . INTRODUCTION Laser Vision Correction one commonly perform elective procedure United States . Although Laser situ keratomileusis ( LASIK ) popular vision correction procedure , grow number surgeon switch surface ablation technique , include PRK , LASEK , Epi-LASIK . In surface laser procedure , epithelium ( clear outer skin cornea ) remove , prior laser reshape cornea . This create epithelial defect take 3-6 day epithelium regenerate . During heal process , patient often report moderate severe ocular pain . A variety treatment utilized reduce postoperative pain . Placement contact lens eye immediate post PRK , show reduce patient discomfort well topical dilute tetracaine , oral medication , even prednisone recommend treatment option pain control . Another method show number study assist reduction post operative pain topical non steroidal anti inflammatory drop . Pain management follow PRK surgery minimize advanced surgical technique , antibiotic , pre- post-operative use topical NSAID solution . We compare use Acuvail 0.45 % administered twice daily Systane Ultra treat post PRK pain . 2 . STUDY OBJECTIVE To evaluate safety efficacy Acuvail 0.45 % administer BID increase re-epithelialization time , decrease time zero pain post-photorefractive keratectomy ( PRK ) surgery assessment PRK enhancement need 6 month post op . CLINICAL HYPOTHESES : Acuvail 0.45 % administered twice daily superior Systane Ultra treat post PRK pain Efficacy Objectives Primary : Time re-epithelialization Secondary : Time zero pain document Patient Comfort Questionnaire PRK enhancement assessment 6 month post op Safety Measures : Visual recovery-UCVA &amp; BCVA IOP Biomicroscopy Adverse Events Optovue OCT-epithelial image Pachymetry Pregnancy test 3 . STUDY DESIGN This Phase 4 , single-center , open label , randomize , contralateral ( one eye receive Acuvail , one eye Systane Ultra Lubricant Eye Drops ) . Patients randomize eye receive Acuvail 0.45 % . The duration study estimate approximately 6.5 month study subject enrol . Controls : Systane Ultra preservative free tear Dosage/Dose Regimen : Study medication administer twice day randomize eye day 1-3 post operatively BID Visit Schedule : Screening ( baseline ) , Day 2-30 ( Surgery ) , post surgery Day 1 , Day 2 , Day 3 , day corneal re-epithelialization , post surgery month 1 , 3 , 6 . Number Patients : 10- subject use study medication one eye , Systane Ultra eye Condition/Disease : patient undergo bilateral PRK surgery Instructions storage , use administration Study medication control medication store secure area room temperature administer patient enter study accordance protocol .</detailed_description>
	<mesh_term>Ketorolac</mesh_term>
	<mesh_term>Ketorolac Tromethamine</mesh_term>
	<mesh_term>Analgesics</mesh_term>
	<mesh_term>Ophthalmic Solutions</mesh_term>
	<criteria>1 . Male female patient , 1839 yr age , good general health 2 . Patient schedule undergo bilateral PRK surgery 3 . The difference two eye ≤ 2 D 4 . Refractive error 1 8 diopter ( spherical equivalent ) baseline 5 . Females childbearing potiential must negative pregnancy test result baseline . A female consider nonchildbearing potential postmenopausal ( menses 12 consecutive month ) without uterus . 6 . Ability follow study instruction likely complete entire course study 7 . Written inform consent obtain 8 . Written HIPPA authorization obtain 1 . Uncontrolled systemic disease 2 . Any active ocular disease , corneal abnormality , lid abnormality , ocular pathology 3 . History serious eye disease , trauma , previous ocular surgery 4 . History unstable myopia 5 . History herpes keratitis 6 . Known allergy hypersensitivity study medication 7 . Anticipated wear contact lenses addition require bandage contact lens postPRK . Patients wear soft contact lenses discontinue wear least 3 day prior baseline visit . Patients wear RGP hard contact lenses discontinue wear least 3 week prior baseline visit . 8 . Females pregnant , breastfeeding , try conceive . 9 . Keratoconus keratoconus suspect 10 . Concurrent participation investigational drug study participation within 30 day prior study start 11 . Any condition situation , investigator 's opinion , may put patient significant risk may confound study result</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>39 Years</maximum_age>
	<verification_date>February 2012</verification_date>
	<keyword>Laser Vision Correction</keyword>
	<keyword>Photorefractive Keratectomy</keyword>
	<keyword>PRK</keyword>
	<keyword>Nearsighted</keyword>
	<keyword>Myopia</keyword>
</DOC>